Internet Explorer 8 Warnung Anscheinend verwenden Sie einen älteren Internet Explorer. Leider unterstützen wir, genau wie Microsoft, diesen Browser nicht mehr. Sie werden also Fehlermeldungen und ein inkonsistentes Design erleben.
Bitte haben Sie Verständnis und entschuldigen Sie die Unannehmlichkeiten.


Successful exit for High-Tech Gründerfonds (HTGF) – HTGF sells its Cytena shares to CELLINK in a trade sale

8. August 2019
The shareholders of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a stronger global presence are just some of the benefits for our More …

HTGF Academy

30. July 2019
HTGF Academy Start-up Workshop Do you know the HTGF Academy?   Since January there is the HTGF Academy. Time for us to draw a first conclusion. “We want to support the founding teams of our portfolio at all levels to succeed their Start-Up successful. This includes training and expertise sharing, that is precisely tailored to their needs,” explains Claudia Raber. She and her team More …

Product-Market Fit in Industrial Tech – The way to customer understanding

30. July 2019
By Ingo Fehr (Investment Manager), Gregor Haidl (Investment Manager), Fabian Hogrebe (Analyst), Yann Fiebig (Senior Investment Manager), Dr. Andreas Olmes (Partner) The founders of Industrial Tech Start-Ups master difficult technological challenges: problems are identified, large problems are broken down into small elements and detailed analyses are performed. For most of the Start-Ups, this way of working solves the most difficult More …

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform

15. July 2019
Acquisition adds key platform supporting Boehringer Ingelheim’s focus on patients with difficult to treat gastrointestinal and lung cancers AMAL’s first in class proprietary KISIMA® platform leverages peptide/protein based vaccination technology AMAL wil l remain at the campus of the University of Geneva in Switzerland and operate as a subsidiary within Boehringer Ingelheim   Boehringer Ingelheim today announced its acquisition of More …

High investor density at the start-up pitch day hosted by IZB

12. July 2019
Twelve project teams presented their top-class research to 19 investors, four pharmaceutical companies, one family office and one industry partner The High-Tech Gründerfonds (HTGF) and the Innovation and Start-up Center Biotechnology (IZB) in Martinsried near Munich organized together with Bayer AG and Boehringer Ingelheim as strategic partners, the “5th Munich Life Science Pitch Day” held on July 11, 2019 at More … closes Series A financing of over 2 million euros

10. July 2019
Berliner Volksbank Ventures, IBB Beteiligungsgesellschaft from its VC fund Kreativwirtschaft, ECONA AG and other business angels are investing more than 2 million euros in the Berlin-based Fintech-Startup remind me GmbH as part of a Series A round. Seed investor High-Tech Gründerfonds (HTGF) is also investing again in this round. The company offers a reminder and optimization service for contracts & More …

“First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment

3. July 2019
The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seed-financing round. The start-up presents a proprietary, innovative technology platform for the development of novel mRNA therapeutics to treat Acute Respiratory Distress Syndrome (ARDS), a severe lung disease. The funds will be used to advance R&D activities and hire additional scientific staff. Investors are the High-Tech Gründerfonds (HTGF), More …

High-Tech Gründerfonds (HTGF) portfolio company MoBerries raises seven-digit Pre-Series A for its AI-based HR platform from international investors.

25. June 2019
MoBerries, headquartered in Berlin, closes a seven-figure funding round from the Abu Issa Investment Group, HTGF, 42CAP, LITTLEROCK and other renowned business angels. MoBerries continues to develop & expand in Germany, solving the inefficiencies in the HR market with the AI-based automated preselection of applicants.   MoBerries builds technology which connects actively seeking candidates to companies by leveraging an AI-based More …

The Gap in the Value Chain of Funding Start-ups is Moving Forward

13. June 2019
This is what usually happens. You take your car and go to the Mediterranean for your holidays. You prepare everything but you don’t think about the fuel your car needs to reach your destination. Although it’s clear that your car needs additional fuel on the way, you are sure to find many stations on your journey offering enough petrol to More …

Simreka closes financing round led by HTGF with participation from the SAP.iO Fund

11. June 2019
Simreka, simulation software that accelerates materials driven product and manufacturing process innovation using AI, today announced that it has raised a seven figure seed financing round led by High-Tech Gruenderfonds (HTGF) with participation from the SAP.iO Fund. Simreka has built a powerful enterprise simulation software and data service that empowers brands and manufacturers to accelerate their R&D cycles and significantly More …